Skip to main content
. 2015 Nov 23;10(11):e0143286. doi: 10.1371/journal.pone.0143286

Fig 2. Survival curves for a composite outcome of head and neck cancer (HNC) recurrence or HNC-attributable death in RA patients exposed to TNF inhibitor therapy and non-biologic (nb) DMARDs.

Fig 2